肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2012年
6期
402-404
,共3页
郗彦凤%白文启%李静%薄云峰%赵圆圆%白玮
郗彥鳳%白文啟%李靜%薄雲峰%趙圓圓%白瑋
치언봉%백문계%리정%박운봉%조원원%백위
胃肿瘤%基因,erbB-2%原位杂交,荧光%免疫组织化学
胃腫瘤%基因,erbB-2%原位雜交,熒光%免疫組織化學
위종류%기인,erbB-2%원위잡교,형광%면역조직화학
Stomach neoplasms%Genes,erbB-2%In situ hybridization,fluorescence%Immunohistochemistry
目的 探讨不同方法检测胃癌中Her-2蛋白表达和基因表达的相关性,寻求胃癌中Her-2检测的有效手段.方法 应用免疫组织化学方法(IHC)对68例胃癌进行Her-2蛋白标记,同时采用荧光原位杂交技术(FISH)检测Her-2基因扩增的情况.结果 68例胃癌患者中,IHC检测Her-2蛋白阳性12例(1765%),分别+++3例,++9例、+7例和-49例;FISH检测Her-2基因扩增11例(16.17%),与IHC阳性强度相对应的FISH检测结果分别为3例(100%)、8例(88.89%)、0例、0例.Her-2基因扩增与Her-2蛋白表达存在相关性(P<0.05).结论 胃癌中存在Her-2蛋白的表达和基因扩增,Her-2蛋白在胃癌中的表达呈现明显的异质性.IHC与FISH检测胃癌Her-2的表达差异主要在IHC++组,IHC++有意愿进行Her-2基因靶向治疗的患者建议进行Her-2基因检测.
目的 探討不同方法檢測胃癌中Her-2蛋白錶達和基因錶達的相關性,尋求胃癌中Her-2檢測的有效手段.方法 應用免疫組織化學方法(IHC)對68例胃癌進行Her-2蛋白標記,同時採用熒光原位雜交技術(FISH)檢測Her-2基因擴增的情況.結果 68例胃癌患者中,IHC檢測Her-2蛋白暘性12例(1765%),分彆+++3例,++9例、+7例和-49例;FISH檢測Her-2基因擴增11例(16.17%),與IHC暘性彊度相對應的FISH檢測結果分彆為3例(100%)、8例(88.89%)、0例、0例.Her-2基因擴增與Her-2蛋白錶達存在相關性(P<0.05).結論 胃癌中存在Her-2蛋白的錶達和基因擴增,Her-2蛋白在胃癌中的錶達呈現明顯的異質性.IHC與FISH檢測胃癌Her-2的錶達差異主要在IHC++組,IHC++有意願進行Her-2基因靶嚮治療的患者建議進行Her-2基因檢測.
목적 탐토불동방법검측위암중Her-2단백표체화기인표체적상관성,심구위암중Her-2검측적유효수단.방법 응용면역조직화학방법(IHC)대68례위암진행Her-2단백표기,동시채용형광원위잡교기술(FISH)검측Her-2기인확증적정황.결과 68례위암환자중,IHC검측Her-2단백양성12례(1765%),분별+++3례,++9례、+7례화-49례;FISH검측Her-2기인확증11례(16.17%),여IHC양성강도상대응적FISH검측결과분별위3례(100%)、8례(88.89%)、0례、0례.Her-2기인확증여Her-2단백표체존재상관성(P<0.05).결론 위암중존재Her-2단백적표체화기인확증,Her-2단백재위암중적표체정현명현적이질성.IHC여FISH검측위암Her-2적표체차이주요재IHC++조,IHC++유의원진행Her-2기인파향치료적환자건의진행Her-2기인검측.
Objective To investigate the association of Her-2 protein expression and gene expression in gastric cancer by different methods,and to explore the effective approaches of Her-2 in gastric cancer detection.Methods Immunohistochemistry (IHC) was used to mark Her-2 protein in 68 cases of gastric cancer,and fluorescence in situ hybridization(FISH)wasused to detect the Her-2 gene amplification.Results Among 68 cases,IHC Her-2 protein in 12 cases(17.65 %)was positive expression,including ++ 3 cases ++ 9 cases,+ 7 cases and-49 cases.By FISH,Her-2 gene in 11 cases(16.17 %)was overexpression.Corresponding to the IHC results,FISH results was 3 cases(100 %),8 cases(88.89 %),0 cases,0 cases,respectively.Conclusion Her-2 protein expression and gene overexpression occur in gastric cancer.Her-2 protein expression in gastric cancer shows significant heterogeneity.Her-2 gene overexpression and Her-2 protein expression is correlated (P<0.05).The differences of Her-2 expression in gastric cancer by IHC and FISH mostly occur in IHC++ groupe.Suggestion of Her-2 gene test should be given for patients with IHC++ who will be undertaken Her-2 gene therapy.